Cook Group said today that it completed the sale of Cook Pharmica to Catalent (NYSE:CTLT).
Catalent announced last month that it planned to dish out $950 million to buy the biologics contract manufacturer. The newly-acquired company will be called Catalent Bloomington, according to Cook Group.
Get the full story at our sister site, Drug Delivery Business News.
The post Catalent reorganizes after closing Pharmica purchase appeared first on MassDevice.
from MassDevice http://ift.tt/2yObWOC
Cap comentari:
Publica un comentari a l'entrada